Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). LifeTech Scientific's share price for the quarter that ended in Jun. 2024 was HK$1.39. LifeTech Scientific's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 4,400 Mil. Therefore, LifeTech Scientific's market cap for the quarter that ended in Jun. 2024 was HK$6,115 Mil.
LifeTech Scientific's quarterly market cap
declined
from Jun. 2023 (HK$12,362 Mil) to Dec. 2023 (HK$10,338 Mil) and
declined
from Dec. 2023 (HK$10,338 Mil) to Jun. 2024 (HK$6,115 Mil).
LifeTech Scientific's annual market cap
declined
from Dec. 2021 (HK$16,946 Mil) to Dec. 2022 (HK$11,945 Mil) and
declined
from Dec. 2022 (HK$11,945 Mil) to Dec. 2023 (HK$10,338 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. LifeTech Scientific's Enterprise Value for Today is HK$4,976 Mil.
LifeTech Scientific Market Cap Historical Data
The historical data trend for LifeTech Scientific's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of LifeTech Scientific's Market Cap
For the Medical Devices subindustry, LifeTech Scientific's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's Market Cap distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
LifeTech Scientific's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeTech Scientific (HKSE:01302) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
LifeTech Scientific Market Cap Related Terms
Thank you for viewing the detailed overview of LifeTech Scientific's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of of advanced minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01302 has been successfully added to your 